EN IT

PHIO — Phio Pharmaceuticals Corp. | Setup 20-24 Jul 2026

PHIO
Phio Pharmaceuticals Corp.
Technical analysis updated on: 2026-07-25 · [ 20-24 Jul 2026 ] - Copyright AiTrading67.com
📅 Earnings · Aug 06, 2026 · in 12d
Stock · US
Inside composite NTZ, bullish bias
SCORE IQS Lite
44/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Weekly Structure 20
Daily Momentum 18
Weekly Ichimoku 0
Daily CMF 0
Delta 6
IQS Lite components · score
STRUCTURE20/30MOMENTUM18/35ICHIMOKU0/19CMF0/6DELTA6/10

IQS Lite analysis - AiTrading67.com · Phio Pharmaceuticals Corp. (PHIO · ISIN US71880W5013)

Weekly Structure
At 20/30 structure is solid: moving averages aligned and underlying trend intact.
Daily Momentum
At 18/35 momentum is positive: impulse building, daily trend accelerating.
Weekly Ichimoku
At 0/19 Ichimoku is fully bearish: price below the cloud, Tenkan and Kijun unsupportive.
Daily CMF
At 0/6 CMF shows outflows: capital leaving and selling pressure.
Delta
At 6/10 the week is slightly positive: close between 0% and +2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
The NTZ compression contains daily momentum fading, while weekly structure maintains bullish strength with free EMA50. The scenario remains promising but requires breakout confirmation beyond critical neutral zone levels.
This week's view by AiTrading67.com
Ordinary phase showing consolidation within the NTZ: the setup awaits confirmation on breakout above 1.11, where daily and weekly MACD signal strong bullish strength. Position remains interesting only on confirmed breakout, with yellow flag from CMF outflows and bearish Ichimoku.
Chart · 12-month trend
Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD
Share WhatsApp Telegram Gmail LinkedIn